Fujifilm Holdings shares experienced a historic collapse, losing 18% in a single trading session. This is the worst result in the brand's history. The reason is disappointing quarterly earnings, which came in significantly weaker than market expectations.

Quarterly Failure: Numbers and Reasons

The company's operating profit for the quarter ending in June was only 51.2 billion yen ($323 million). This is a third below the consensus forecast of analysts, who expected 77.1 billion yen. The main pressure factors were rising raw material costs and one-time expenses. Additionally, core profit declined in key segments—healthcare and business solutions.

The situation is compounded by the fact that, in my assessment, this is not a one-time glitch. There is a systemic deterioration in profitability at the company's manufacturing core. Recovery to previous profitability levels will require significantly more time than management's optimism suggests.

Rescue Strategy: Business Spin-off

In response to the crisis, Fujifilm's management announced plans to partially spin off the Fujifilm Business Innovation division (formerly Fuji Xerox), which generates about 35% of all revenue. The scheme is as follows: Fujifilm will retain just under 20% of the shares, while the rest will be distributed to shareholders as dividends in kind. After that, the division will be listed on the Tokyo Stock Exchange.

The expectation is that the spin-off will take two to three years and require shareholder approval, as well as depend on tax implications under Japanese law. The Fujifilm brand will remain part of the spun-off business.

This step fits into the long-term VISION2030 strategy, where the priority shifts from revenue growth to capital efficiency and profitability. However, in my view, such restructuring is a double-edged sword. On one hand, it could unlock value for shareholders. On the other, losing control over a third of the business carries risks to operational synergy and makes the company more vulnerable in the short term.

Context and Conclusions

Fujifilm is not alone in its problems—the Japanese market is going through a challenging earnings season. For example, Kioxia shares also collapsed after revising forecasts. However, some analysts maintain cautious optimism about the sector's recovery.

It is still unclear whether investors will support such radical restructuring. The market is in a state of uncertainty, and trust in management has been undermined. I believe the current situation requires increased caution from investors: reforms may take longer and prove less effective than expected. This is a classic case where the "medicine" may be no less painful than the "disease" itself.